Claire L. Green

1.1k total citations
6 papers, 819 citations indexed

About

Claire L. Green is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Claire L. Green has authored 6 papers receiving a total of 819 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hematology, 4 papers in Genetics and 2 papers in Molecular Biology. Recurrent topics in Claire L. Green's work include Acute Myeloid Leukemia Research (5 papers), Retinoids in leukemia and cellular processes (2 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). Claire L. Green is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Retinoids in leukemia and cellular processes (2 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). Claire L. Green collaborates with scholars based in United Kingdom, Australia and United States. Claire L. Green's co-authors include Rosemary E. Gale, David C. Linch, Robert K. Hills, Alan K. Burnett, C. M. Evans, Alan K. Burnett, Kenneth Koo, Lu Zhao, Valeria R. Fantin and P. Andrew Futreal and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and Blood.

In The Last Decade

Claire L. Green

6 papers receiving 804 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claire L. Green United Kingdom 5 504 359 296 223 148 6 819
Sam Agresta United States 15 442 0.9× 474 1.3× 285 1.0× 315 1.4× 127 0.9× 27 912
Katherine Waghorn United Kingdom 10 660 1.3× 730 2.0× 500 1.7× 115 0.5× 75 0.5× 13 1.2k
María José Larráyoz Spain 19 417 0.8× 405 1.1× 268 0.9× 87 0.4× 38 0.3× 34 801
Zineb Hamilou Canada 6 408 0.8× 265 0.7× 238 0.8× 134 0.6× 44 0.3× 18 652
Suxia Geng China 16 350 0.7× 380 1.1× 361 1.2× 161 0.7× 85 0.6× 67 971
Anne Murati France 18 866 1.7× 640 1.8× 598 2.0× 121 0.5× 48 0.3× 28 1.2k
Anna Aventı́n Spain 20 495 1.0× 372 1.0× 317 1.1× 61 0.3× 69 0.5× 58 938
Ashwin Kishtagari United States 11 564 1.1× 305 0.8× 323 1.1× 221 1.0× 60 0.4× 56 857
Annette Fasan Germany 14 676 1.3× 646 1.8× 299 1.0× 258 1.2× 188 1.3× 34 1.2k
Stephanie A. Smoley United States 16 302 0.6× 226 0.6× 571 1.9× 91 0.4× 69 0.5× 44 908

Countries citing papers authored by Claire L. Green

Since Specialization
Citations

This map shows the geographic impact of Claire L. Green's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire L. Green with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire L. Green more than expected).

Fields of papers citing papers by Claire L. Green

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claire L. Green. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire L. Green. The network helps show where Claire L. Green may publish in the future.

Co-authorship network of co-authors of Claire L. Green

This figure shows the co-authorship network connecting the top 25 collaborators of Claire L. Green. A scholar is included among the top collaborators of Claire L. Green based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claire L. Green. Claire L. Green is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Green, Claire L., Kiran Tawana, Robert K. Hills, et al.. (2013). GATA2 mutations in sporadic and familial acute myeloid leukaemia patients with CEBPA mutations. British Journal of Haematology. 161(5). 701–705. 38 indexed citations
2.
Amary, Maria Fernanda, Stephen Damato, Dina Halai, et al.. (2011). Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2. Nature Genetics. 43(12). 1262–1265. 276 indexed citations
3.
Green, Claire L., C. M. Evans, Lu Zhao, et al.. (2011). The prognostic significance of IDH2 mutations in AML depends on the location of the mutation. Blood. 118(2). 409–412. 204 indexed citations
4.
Green, Claire L., Kenneth Koo, Robert K. Hills, et al.. (2010). Prognostic Significance of CEBPA Mutations in a Large Cohort of Younger Adult Patients With Acute Myeloid Leukemia: Impact of Double CEBPA Mutations and the Interaction With FLT3 and NPM1 Mutations. Journal of Clinical Oncology. 28(16). 2739–2747. 197 indexed citations
5.
Green, Claire L., C. M. Evans, Robert K. Hills, et al.. (2010). The prognostic significance of IDH1 mutations in younger adult patients with acute myeloid leukemia is dependent on FLT3/ITD status. Blood. 116(15). 2779–2782. 103 indexed citations
6.
Green, Claire L., C. M. Evans, Robert K. Hills, et al.. (2010). Younger Adult Acute Myeloid Leukemia (AML) Patients with IDH2-R140 Mutations Have a Significantly Better Prognosis Than Those with Either IDH2-R172 or IDH1 Mutations. Blood. 116(21). 100–100. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026